Skip to main content
Blizard Institute - Faculty of Medicine and Dentistry

Professor Joanne Martin, MA MB BS MA PhD RCPathME FIBMS (Hon) FFPH (Hon) FRCPI (Hon) FRCPath


Deputy Vice Principal Health

Centre: Centre for Genomics and Child Health

Telephone: +44 20 3246 0118
Twitter: @JoMartin_path


Professor Martin qualified Cambridge University and London Hospital Medical College, has a University of London PhD and Masters in Leadership. She has over 130 published papers including Nature group and Science journals and is Deputy Vice Principal (Health) and Professor of Pathology at Queen Mary University London. Her clinical specialist expertise is in the pathology of gastrointestinal motility disorders. 

She is an award winning eCPD app designer and co-founder of Biomoti, a drug delivery development company. She developed and leads an innovative multi-million pound adaptive learning programme for RCPath and Health Education England.

She served as a director on the Board of Barts Health NHS Trust for 5 years. She has very broad experience in healthcare management including responsibility for local and regional research and for the training and education of over 17,500 staff.

National Clinical Director of Pathology for NHS England April 2013-16, Jo was President of the Royal College of Pathologists from November 2017-2020, and is now National Specialty Advisor for Pathology for NHS England and Improvement, chairing the national Pathology Board and the national Pathology Workforce Board. She has led the profession during the pandemic and ensuing incidents related to global and national pressures.

She has worked with international charities, including as Chair of the Research Advisory Board of the Motor Neuron Disease Association, with which she has a long association, and with local charities, including as a volunteer vaccinator throughout the COVID-19 vaccine programme.


BSc Experimental Pathology Chair


Research Interests:

Research into neuromuscular disorders of the gastrointestinal tract in particular clinically important dysmotility disorders. The genetic basis and pathogenesis of disease. Investigation of digital systems of education and the interoperability of digital systems with a focus on digital pathology and laboratory information management systems.


Key Publications

  • Blaydon DC, Biancheri P, Di WL, Plagnol V, Cabral RM, Brooke MA, van Heel DA, Ruschendorf F, Toynbee M, Walne A, O'Toole EA, Martin JE, Lindley K, Vulliamy T, Abrams DJ, MacDonald TT, Harper JI, Kelsell DP. Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med 2011 365(16):1502-1508 20
  • Broad J, Kung VWS, Palmer A, Elaine S, Karami A, Chin-Aleong J, Martin JE, Saffrey MJ, Knowles CH, Sanger GJ. Changes in neuromuscular structure and functions of human colon during ageing are region-dependent. Gut. 2019 Jul;68(7):1210-1223
  • Alić, I., Goh, P.A., Murray, A. et al. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain. Mol Psychiatry 2020.
  • Nightingale JMD, Paine P, McLaughlin J, Emmanuel A, Martin JE, Lal S, on behalf of the Small Bowel and Nutrition Committee and the Neurogastroenterology and Motility Committee of the British Society of Gastroenterology.  The management of adult patients with severe chronic small intestinal dysmotility Gut 2020;69:2074-2092.
  • Martin JE, English W, Kendall JV, et al.  Megarectum: Systematic histopathological evaluation of 35 patients and new common pathways in chronic rectal dilatation Journal of Clinical Pathology 
    Published Online First: 25 May 2021. doi: 10.1136/jclinpath-2021-207413

All Publications

Back to top